Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders Equity

Schedule of Shares Issued to Consultants and Vendors

The following shares were issued to consultants and vendors for the year ended December 31, 2024:

Description	Origination Date	Shares		Fair Value		Settlement Date	Fair Value at Settlement		Change in Fair Value
Settlement of liability with consultants	January 2024		100,000	$	195,000	September 2024	$	219,500	$	(24,500	)
Settlement of liability with consultants	April 2024		60,000		240,600	June 2024		183,600	$	57,000
Issuance of common stock to consultant	June 2024		60,000		183,600	June 2024		183,600	$	—
Settlement of liability with consultants	July 2024		50,000		164,000	September 2024		109,750	$	54,250
Issuance of restricted common stock to consultants	September 2024		150,000		—	September 2024		—	$	—
Settlement of liability with consultants	December 2024		135,000		531,000	December 2024		642,000	$	(111,000	)
			555,000	$	1,314,200		$	1,338,450	$	(24,250	)

The following shares were issued to consultants and vendors for the year ended December 31, 2023:

Description	Origination Date	Shares		Fair Value		Settlement Date	Fair Value at Settlement		Change in Fair Value
Issuance of common stock in lieu of commissions	October 2022		57,250	$	90,455	March 2023	$	75,570	$	14,885
Settlement of liability with consultants	November 2022		12,500		50,000	August 2023		18,125	$	31,875
Settlement of liability with consultants	February 2023		100,000		172,500	August 2023		145,000	$	27,500
Settlement of liability with consultants	March 2023		100,000		93,700	August 2023		145,000	$	(51,300	)
Issuance of common stock to settle share liability	May 2023		100,000		65,100	November 2023		152,000	$	(86,900	)
Issuance of common stock to settle share liability	May 2023		50,000		30,900	November 2023		76,000	$	(45,100	)
Settlement of liability with consultants	July 2023		150,000		181,500	August 2023		248,000	$	(66,500	)
Settlement of liability with consultants	August 2023		100,000		126,000	August 2023		145,000	$	(19,000	)
			669,750	$	810,155		$	1,004,695	$	(194,540	)

Schedule of Share Liability

Activity of the share liabilities for the year ended December 31, 2024 is as follows:

	Share Liabilities as of December 31, 2023		New Share Liabilities in 2024		Mark to Market Adjustments in 2024		Liabilities Settled in 2024			Share Liabilities as of December 31, 2024
Share liabilities	$	—	$	1,130,600	$	24,250	$	(1,154,850	)	$	—

Activity of the share liabilities for the year ended December 31, 2023 is as follows:

	Share Liabilities as of December 31, 2022		New Share Liabilities in 2023		Mark to Market Adjustments in 2023		Liabilities Settled in 2023			Share Liabilities as of December 31, 2023
Share liabilities	$	140,455	$	669,700	$	194,540	$	(1,004,695	)	$	—

Schedule of Assumptions Used for Fair Value of Warrants

The fair value of these warrants was determined to be $2,882,621 and estimated based on the Black-Scholes model, using the following assumptions:

Expected volatility	60.3	%
Weighted-average risk-free rate	3.44	%
Expected term in years	5.5
Expected dividend yield	—	%

The fair value of the Inducement Warrant was determined to be $2,779,659 and estimated based on the Black-Scholes model, using the following assumptions:

Expected volatility	73.5	%
Weighted-average risk-free rate	4.37	%
Expected term in years	5.5
Expected dividend yield	—	%

The fair value of the Commission Warrant was determined to be $657,871 and estimated based on the Black-Scholes model, using the following assumptions:

Expected volatility	73.5	%
Weighted-average risk-free rate	4.60	%
Expected term in years	5.5
Expected dividend yield	—	%